Genentech, Roche Deal Hits Snag

WSJ.com: What's News US, Wall Street Journal
Wed, 03/11/2009 - 9:26am

Deal talks between Genentech and Roche hit a snag over dueling interpretations of arcane SEC rules, but the problem is unlikely to derail the transaction, according to people familiar with the matter.

Sections: business

Topics: drugs drugs industry genentech mergers & acquisitions roche holding

Microsoft may buy Barnes & Noble's Nook unit for $1 billion
According to internal documents obtained by the website TechCrunch, Microsoft has offered $1 billion for the digital assets of Nook Media, Barnes & Noble's digital book venture. According to internal documents obtained by the website TechCrunch, Microsoft has offered $1 billion for the digital assets of Nook Media, Barnes & Noble's digital book venture. More
Bayer to pay $1.1B for California firm Conceptus
Germany drug company Bayer AG says it intends to buy California-based Conceptus to expand its birth control offerings. Bayer said Monday it would launch a pupublicblic offer to pay $31.00 per share for all the stock in Conceptus, Inc. That means Bayer would pay $1.1 billion. More
Cancer Physicians Attack High Drug Costs
More than 100 cancer specialists have banded together to persuade pharmaceutical companies to bring prices down, suggesting that the high prices for medicine needed to keep someone alive is profiteering. More
Swedish police find drugs on Bieber tour bus
The latest chapter in Justin Bieber's European tour escapade was added Thursday when Swedish police said they had found drugs and a stun gun on the pop singer's bus. Lars Bystrom, spokesman for the Stockholm police, told The Associated Press a small amount of drugs and a stun gun were discovered during a search of the bus, which had been parked under the Globen concert venue in Stockholm, where Bieber was performing Wednesday. More
Dish's $25.5 billion Sprint bid may force others to act
Dish Network Corp, the No. 2 U.S. satellite television provider, on Monday offered to buy wireless service provider Sprint Nextel Corp for $25.5 billion in cash and stock, a move that could inspire other telecommunications or video companies to consider their own prospects of combining. More

Place your ad here
Loading...

BING NEWS:

AbbVie’s Deal for Alzheimer’s Antibody Raises Curtain for Roche News on Wednesday
The transaction, seen as a vote of confidence, has put the focus on other drug firms testing similar barrier-bridging antibodies.
10/31/2024 - 10:25 am | View Link
Post-Hoc: Novo’s obesity enemies
This week, Roche joined Eli Lilly in coming out against a deal that would add significant new manufacturing capacity to Novo Nordisk, to help it meet some of the huge ...
10/25/2024 - 5:19 am | View Link
Dyno has another AAV deal, its second with Roche for $1B
Privately held Dyno Therapeutics Inc. has added another notch to its adeno-associated virus (AAV) vectors development portfolio in a deal with the Roche Group that includes $50 million up front and ...
10/24/2024 - 11:13 am | View Link
Roche Inks Potential $1B Gene Therapy Deal With Dyno, Eyes Neurological Diseases
With an upfront payment of $50 million from Roche, the partnership will leverage Dyno Therapeutics’ in vivo gene therapy delivery technology, which synthesizes virus capsids with better functionality ...
10/24/2024 - 3:39 am | View Link
Dyno signs second Roche deal worth over $1B
George Church-founded Dyno Therapeutics Inc. is adding to its list of pharma deals by signing a second research collaboration with Roche. The Watertown biotech is in line to get $50 million upfront ...
10/23/2024 - 1:00 pm | View Link
More